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Abstract
  
 Interferon-gamma (IFN-γ) is one of the central cytokines in the anti-carcinogenesis 
immune response.  Black cumin seeds (BCS) have an active content of thymoquinone and 
unsaturated fatty acids with biological activity as immunomodulators. This study aimed 
to determine the effect of administration of BCS extract on IFN-γ secretion activity by 
DMBA-induced SD rat lymphocytes. In vivo experimental study on DMBA-induced SD rats, 
BCS extract was given with three doses for two weeks before being induced and five weeks 
during DMBA induction. IFN-γ levels in lymphocyte culture supernatants were determined 
by the ELISA method. The difference in IFN-γ levels between groups was analyzed by 
ANOVA test, the significance of 95%. The results showed that administration of BCS extract 
for 14 days did not affect cellular composition toward the edge of the test animal. BCS 
extract can increase IFN-γ secretion activity by DMBA-induced SD rat lymphocytes. 
Keywords: black cumin seed, IFN-γ; DMBA: immunomodulator, carcinogenesis.
INTRODUCTION 
 The immune system with immunosur-
veillance is a vital component that is responsible 
for the development of cancer of a neoplastic cell 
(Dembic, 2015; Disis, 2010; American Cancer So-
ciety, 2016; Li, et al., 2019). The development of 
proto-oncogenes into cancerous oncogenes that 
are evolutionarily is thought to be one of them 
caused by a decrease in the ability of the host im-
munosurveillance (Baj-Krzyworzeka, et al., 2004) 
(Ballestero Fêo, et al., 2018). The host’s response 
to cancer is a complex mechanism, involving com-
ponents of the regulatory system, phagocyte effec-
tor activity and immune system mediators (Hay-
akawa, et al., 2002) (Ren, et al., 2019; Selinger, 
et al., 2018; Upadaya, et al., 2018). Interferon-
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gamma (IFN-γ) is one of the anti-carcinogenesis 
pro-inflammatory cytokines, is one of the regula-
tory system immune response, due to exposure 
to dimethylbenzanthracene (Castro, et al., 2018). 
Unfortunately, until now, it has not been widely 
studied, primarily when associated with immuno-
gens from plants that have the potential as immu-
nomodulators and also as chemopreventives (Dunn, 
et al., 2004; Zekri, et al., 2018; Li, et al., 2002). 
 One of the plants that empirically and lab-
oratory has been used as chemopreventive as well 
as immunomodulators is black cumin seed (BCS) 
or Nigella Sativa (Shaterzadeh-Yazdi, et al., 2018; 
Hidayati, et al., 2019; Badr, et al., 2011; Randhawa, 
et al., 2011; Soliman, et al., 2017). Nigella sativa 
seeds (N.sativa) contain various active compounds 
which are thought to be immunomodulatory as well 
as cancer chemopreventives (El-Mahmoudy, et al., 
2002). Mousa (2004) proved that BCS could pro-
vide chemopreventive effects in vivo in DMBA-in-
duced mice carcinogens (Mousa, et al., 2004). 
BCS administration for 14 days in mice induced 
with 7,12-di-methylbenz(a)anthracene (DMBA) 
reduces tumor markers and increases TNF α levels 
as a factor driving DNA apoptosis and fragmenta-
tion (Odhaib, et al., 2018). In Swiss mice- infected 
plasmodium berghei (P.berghei), the ethanolic ex-
tract of BCS was shown to increase the phagocytic 
activity of macrophages (Hidayati, 2006). Adminis-
tration of BCS oil in mice induced with streptozo-
tocin has been shown to increase phagocytosis of 
peritoneal macrophages (Fajar, et al., 2017). Immu-
nomodulatory activity of the BCS can optimize the 
immune response to foreign substances or antigens, 
including neoplasmic antigens (el Aziz, 2005; Gho-
lamnezhad, et al., 2019; (Hidayati, et al., 2017).
 DMBA compounds are genotoxic and im-
munotoxic. Genotoxic indirectly from DMBA has a 
mechanism through cytochrome P450-mediated en-
zymatic or biotransformation activation and gluta-
thione-S-transferase activity (Parmar, et al., 2011). 
These conversions produced electrophilic, which 
can react with several nucleophilic compounds in 
proteins, DNA, and RNA. Cancer cells start on the 
occurrence of mutations of protooncogene into on-
cogenes (Barletta, et al., 2004). The variation in 
the p53 gene will lead the mutant cells to avoid the 
mechanism of apoptosis so that it will stay alive and 
develop into cancer cells (Gao, et al., 2008). Neo-
plastic cells will be recognized as non-self by the 
immune system, which will then generate an im-
mune response. Peptides from H-ras gene mutations 
induce T cell proliferation in vitro. Single-point 
mutations in oncogenic H-Ras and p53 genes trig-
ger tumors with the potential to form T-cell specific 
epitopes. Activation of cellular immune responses 
through the CD4 T cells  increase the phagocytic ac-
tivity of effector cells (CTL, macrophages, and NK 
cells) and increase the production of cellular immune 
response regulators, among others, IFN-γ, TNF α 
and IL-2. The immune system as a body surveil-
lance system will prevent neoplastic cells towards 
tumor tissue formation and subsequent carcino-
genesis (Soliman, et al., 2017) (Ren, et al., 2018).
 Black cumin seeds are empirically, labora-
tories and clinically proven to be safe, and tolera-
ble (Akrom, et al., 2017) (Rachman, et al., 2017). 
The administration of BCS is thought to increase 
the immune response in neoplasms (Akrom, et 
al., 2017; Al Ghamdi, 2002. From previous stud-
ies it has been proven that administration of BCS 
oil in Balb c mice infected with cytomegalovirus 
has been shown to prevent infection and increase 
IFN-γ levels and CD4 number and activity (Shat-
erzadeh-Yazdi, et al., 2018). Administration of BCS 
ethanol extract has been shown to be effective in 
inhibiting carcinogenesis and improving immune 
responses (Hidayati, et al., 2006; Randhawa, et al., 
2011). The administration of BCS ethanolic extracts 
in doses of 250 mg/kg BW  was proven to be able 
to inhibit carcinogenesis (Fathy, 2013). IFN-γ is a 
pleiotropic anti-carcinogenesis cytokine and plays 
an important role in regulating the anti-carcinogen-
esis immune response. IFN-γ is associated with an-
tiproliferative, pro-apoptotic, and antitumor mecha-
nisms (Ren, et al., 2019). Until now how the effect 
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of BCS ethanolic extract on IFN-γ levels in SD rats 
induced by DMBA has not been studied. Black 
cumin seed (BCS) is expected to increase IFN-γ se-
cretion activity by lymphocyte of  DMBA-induced 
SD rats.The purpose of this study was to determine 
the effect of BCS administration to IFN-γ secretion 
activity of DMBA-induced SD mice lymphocytes.
METHODS
 
 This study was an experimental labora-
tory with the control group. Test animals were di-
vided into seven groups randomly, group one as a 
healthy control group (solvent group), group two as 
a sick control group (DMBA group), group three 
to five  as the treatment groups, group six as Im-
boost group (positive control group 1), and group 
seven as a tamoxifen group (positive control 
group 2). The study protocol has been reviewed 
and declared ethically viable by the research eth-
ics committee of Universitas Ahmad Dahlan, Yo-
gyakarta, Indonesia (No. 043/KEP-UAD/II/2019).
Animal, Material and Equipment 
 The study was conducted at the animal 
breeding and experimental unit of Gadjah Mada 
University. We used 7,12 dimethylbenzanthracene 
(DMBA, Sigma-Aldrich, St Louis, USA) for induc-
ing carcinogenesis. We obtained a DMBA from one 
of the official distributors in Yogyakarta. We used 
corn oil as solvent DMBA, as in previous studies 
(Hidayati, et al., 2019). Sprague Dawley (SD) rat 
test animals were obtained from the  Animal Breed-
ing and Experimental Unit, Gadjah Mada Uni-
versity. We used 105 female SD rats strain, aged 
14-30 days with an average weight of 60-80 g. A 
twenty one female SD rats are for the preliminary 
test, and 84 are for the examination of BCS prep-
aration. The BCS preparation is ethanolic extract 
of BCS. Ethanol extract of BCS has been provided 
by the Department of Pharmaceutical Biology, 
Pharmacognition and Phytochemistry, Faculty of 
Pharmacy, Ahmad Dahlan University. “Imboost” 
preparations, one of the immunomodulatory prep-
arations and have obtained a marketing authoriza-
tion from the Republic of Indonesia drug and food 
control agency, were obtained by prescription from 
a pharmacy, as positive control 1. Tamoxifen cit-
rate (Nolvadex), a preparation for chemotherapy 
in breast cancer patients in Indonesia, is used as a 
positive control 2. Tamoxifen is obtained from a 
pharmacy using a prescription from a doctor. We 
used an IFN-γ (Quantikine, R & D system, Inc. 
Minneapolis, USA) elisa kit to determine IFN-γ 
levels in the supernatant culture of limpocytes. 
.
Experimental Procedure
 Test animals with age as needed, after 
ensuring their health by trained personnel, then 
weighed in order to obtain test animals in accor-
dance with the criteria. Test animals are then placed 
in plastic cages. During the experiment the test 
animals were kept at the appropriate temperature 
and humidity of the room, had adequate lighting 
and got standard food and drink. Test animal care 
is carried out by certified trained personnel in the 
Unit of care and breeding of test animals, Gajah 
Mada University. Test animals are acclimatized 
for one week before being used for experiments.
 Test animals were divided into seven 
groups randomly, twelve animals each group..
Group one as solvent group, during the trial period 
the test animals get additional treatment viz  1x0.5 
ml/day per oral of corn oil, but without inducing 
DMBA. Group two as a DMBA (sick) group, In 
the first two weeks of the experimental period the 
test animals have not received additional treatment, 
starting form third week of experimental perode 
the test animals were given preparations contain-
ing DMBA 20 mg/kg BW in 0.5 ml of solvent corn 
oil given 2x/week per peritoneal for five weeks. 
All test groups, except the solvent group, received 
DMBA preparations starting from the third week 
of treatment. Group three to five as the treatment 
groups, the test animal received BCS preparation in 
three doses. BCS preparations was carried out start-
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ing from 14 days before the first DMBA adminis-
tration and continued for five weeks during DMBA 
administration, i.e. from 4th weeks of age to 11th 
weeks of age, 1x/day orally at doses of 5.25 and 125 
mg/kgBW/day. BCS preparations were given with 
three dose ratings based on the results of previous 
studies (el Aziz, et al., 2005; Karimi, et al., 2011). 
Group six as Imboost group, the test animals were 
given immunomodulatory (Imboost) preparations 
according to the dose in adults who were converted 
into rat doses. The preparation is given once a day 
two weeks before DMBA induction and two weeks 
during the DMBA induction period so that the total 
administration is four weeks. The preparation com-
pany recommends that Imboost be used no more 
than 4 weeks. Group seven as a tamoxifene group, 
the preparations was given as the way to adminis-
ter other preparations, two weeks before DMBA 
induction and five weeks during DMBA induction. 
Six-week-old rats were given a DMBA solution in 
corn oil at a dose of 20 mg/kg BW orally. DMBA 
induction was repeated ten times with the frequency 
of administration twice a week. (Zekri, et al., 2018).
Hemogram and Lymphocyte Activity in  se-
creting IFN-γ Test Procedure 
 Hemogram measurements of the animal 
were carried out 14 days after administration of BCS 
extract. Blood was isolated from sinus orbitalis by 
professional trained. We examined hemogram with 
hemoanalyzer. In the 15th and 50th day, we sacrificed 
the animal study. The spleen organ was isolated after 
two and seven weeks  administration of BCS prep-
aration and after DMBA induction was completed. 
Lymphocytes were isolated and cultured following 
the procedures of previous researchers (Soliman, et 
al., 2017). IFN-γ levels of splenocyte culture su-
pernatants were measured by Enzyme-Linked Im-
munosorbent Assay (ELISA) sandwiches. The kit 
used was quantikine M from R & D System, Inc. 
Minneapolis, USA. Examination procedures as per 
the procedures provided by the factory. The test re-
sults were read by ELISA reader at a wavelength 
of 450 nm, IFN-γ levels  were expressed as pg/mL. 
Data Analysis 
 The difference in IFN-γ secretion ac-
tivity by lymphocytes and the average num-
ber of blood cells between groups was analyzed 
by ANOVA, with a confidence level of 95%. 
RESULTS
Hemogram of Experimental Animals
 The results of blood tests after administra-
tion of BCS preparations for 14 days showed that 
there were no changes in the cellular composition 
of the blood of the test animals, as shown in Table 1.
 From table 1, it is known that the ad-
ministration of BCS for 14 days does not af-
fect the composition of the hemogram. 
IFN-γ secretion lymphocytes activity be-
fore and after DMBA induction by the ad-
ministration of BCS ethanolic extract
Lymphocytes are isolated from the spleen organs. 
Table 2 presents the  IFN-γ levels that secreted by 
lymphocyte culture. In this experiment as a base-
line is the DMBA group before DMBA induced. 
Before the DMBA was induced, the DMBA group 
got standard food and drink. Before the DMBA 
was induced, the treatment group and the control 
group received additional treatment according to 
their group for two weeks besides getting standard 
food and drink. Research data shows that before 
being induced by DMBA, the DMBA group and 
the solvent group had equivalent IFN-γ levels, i.e 
80±9 and 80 ± 9 pg/mL (p>0.05). Provision of corn 
oil for 2 weeks does not affect the activity of lym-
phocytes in secreting IFN-γ. In contrast to the sol-
vent group, administration of BCS, thymoquinone 
and tamoxifen preparations for two weeks increase 
lymphocyte activity in secreting IFN-γ. The high-
est IFN-γ level was in the with 125 mg/kg BW/
day BCS  group (336+49pg/mL), then followed 
by a group of 25 mg/kg BW/day BCS (304+15pg/
mL) and Imboost group (291.7+55p/mL). Before 
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induced DMBA, the treatment group and the posi-
tive control group had IFN-γ levels higher than the 
IFN-γ levels of the solvent and the DMBA group 
(p<0.05).
 The administration of BCS dosages 5, 25, 
and 125 mg/kg BW/day for 14 days increase IF-
N-γ secretion activity by lymphocytes. The BCS 
dosage group with a dose of 125 mg/kg after giv-
ing 14 had the highest IFN-γ secretion activity, 
higher than the Imboost and Tamoxifen group but 
not statistically significant. In eexperimental group, 
the BCS group with a dose of 5 mg/kg BW/day 
had the lowest IFN-γ secretion activity but was 
higher than the DMBA group and solvent group. 
 Five weeks administration of corn oil 
during the DMBA induction period in the solvent 
group did not affect the lymphocyte activity in se-
creting IFN-γ. In the solvent group, IFN-γ levels 
before and after the DMBA induction period were 
not different  (p>0.05). During the DMBA  induc-
tion period the solvent group received additional 
treatment that is given corn oil once per day   orally.
 DMBA induction decreases lymphocyte 
activity in secreting IFN-γ. In the DMBA group, 
the IFN-γ levels after induction were lower than be-
fore DMBA induced and were statistically signifi-
cant (72±2.7 pg/mL v.s. 87±11.2 pg/mL, p<0.05, 
p<0.05). Measurement of IFN-γ levels after five 
weeks of induced DMBA, the DMBA group had 
the lowest level. The IFN-γ level of DMBA group 
was lower than the solvent group (72±2.7 pg/mL 
v.s. 83±10.2, p<0.05). MBA induction reduced 
IFNγ levels in all experimental groups except the 
125 mg/kg BW BCS group. In the 125 mg/kg BW 
BCS group, IFN-γ levels after DMBA induction 
were higher than before DMBA induced (690±54.1 
pg/mL v.s. 336+49, p<0.05).
 Administration of BCS, imboost and ta-
moxifen preparations increase lymphocyte activity. 
The research data showed that IFN-γ levels in 25 
and 125 mg/kg BW BCS groups were higher than 
IFN-γ levels in the Imboost or Tamoxifene group 
(p <0.05). After the duration of DMBA induction, 
among the treatment groups, the 125 mg/kgBW 
BCS group had the highest IFN-γ levels, followed 
by the 25 mg/kgBW BCS group, the Imboost group, 
the 5 mg/kg BW BCS group and the lowest is ta-
moxifene group.
Table I. Composition of blood cells of test animals after obtaining 5, 25, and 125 mg/kgBW/day of BCS 
preparation for two weeks
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DISCUSSION
 DMBA induction in test animals decreases 
lymphocyte activity in secreting IFN-γ. The IFN-γ 
secreted by the negative control group (DMBA) 
was the lowest. IFN-γ level of a negative con-
trol (DMBA) was lower than the solvent group 
(p<0.05). Administration of BCS preparations can 
inhibit decreased lymphocyte activity in securing 
IFN-γ due to DMBA induction. In the group that 
had received BCS dosages of 5 and 25 mg/kg/day, 
imboost and tamoxifen decreased IFNγ secretion 
activity due to DMBA induction, but the activ-
ity of IFN-γ secretion by lymphocytes remained 
higher than the negative control group (p<0.05). 
The group of BCS preparations with a dose of 125 
mg/kg BW/day did not decrease due to DMBA in-
duction. The level of IFN-γ of lymphocyte culture 
supernatant in the BCS group dosage of 125 mg/
kg BW/day after DMBA induction increased if 
compared to DMBA induced (p<0.05). Polycyclic 
aromatic hydrocarbons (PAHs) are ubiquitous en-
vironmental contaminants that are carcinogenic and 
immunosuppressive. Previous studies show that IP 
administration of DMBA to mice results in a sub-
stantial hypocellularity of the bone marrow at 48 
h after exposure (Gao, et al., 2008). This response 
was dependent on local metabolism of the DMBA 
by Cyp1b1 that is expressed in the bone marrow, 
spleen, thymus, and peripheral blood leukocytes, 
but not the liver parenchyma (Xiao, et al., 2009) 
(Buters, et al., 2003). The reduction in bone mar-
row cellularity was evident in both the lymphoid 
(B cell) and myeloid (largely granulocyte) popula-
tions (Ichihara, et al., 2003; N’jai, et al., 2010). Al-
though these previous studies identified the adverse 
effects of DMBA on bone marrow hematopoiesis, 
they did not examine whether exposure to DMBA 
changes the ability of lineage-specific progenitor 
cells to proliferate and differentiate into mature 
bone marrow cell populations (Gao, et al., 2008). 
Lymphocytes produce IFN-γ cytokines after getting 
stimulation from antigens, inflammatory mediators, 
or other cytokines produced by macrophages or 
neutrophils due to antigen exposure  (Upadhyay, et 
al., 2018). Gamma interferon plays a role in reg-
ulating natural and adaptive immune responses. 
IFN-γ has been shown to inhibit carcinogenesis, 
neoplasm formation, and activate antitumor im-
munosurveillance (Selinger, et al., 2018). Thymo-
quinone and the active ingredient BCS are proven 
to be able to increase the activation of natural and 
adaptive immune responses and anti-carcinogene-
sis. Based on the results of this study, it is known 
Table 2. IFN γ secretion activity by Sprague Dawley rat lymphocytes after obtaining black cumin seed eth-
anolic extract for 14 days before and five weeks during DMBA-induction
note: *=p<0.05 to normal/solvent group; a=p<0.05 after DMBA-induction>before DMBA-induction; b=p<0.05 
after DMBA-induction<before DMBA-induction.
 146
Indonesian Journal of Cancer Chemoprevention, October 2019
ISSN: 2088–0197
e-ISSN: 2355-8989
that activation of the immune response by thymo-
quinone and BCS active substances is one of them 
through increased lymphocyte activity (Shaterzade-
h-Yazdi, et al., 2018; Mollazadeh, et al., 2017).
CONCLUSION
 From this study, it can be concluded that 
the administration of ethanolic extract of BCS for 
14 days did not affect the peripheral blood cellu-
lar composition and the administration of BCS 
preparation proved to increase IFN-γ secretion 
activity by lymphocytes and inhibit DMBA ac-
tivity in suppressing lymphocyte activity. BCS 
dosages of 125 mg/kgBW/day have lympho-
cytes with the highest IFN-γ secretion activity. 
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